313 Shares in HealthEquity, Inc. $HQY Bought by Caitong International Asset Management Co. Ltd

Caitong International Asset Management Co. Ltd bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 313 shares of the company’s stock, valued at approximately $33,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC boosted its position in shares of HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after acquiring an additional 172 shares during the last quarter. WPG Advisers LLC bought a new position in shares of HealthEquity during the first quarter worth $28,000. Cullen Frost Bankers Inc. boosted its position in shares of HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares during the last quarter. Sellwood Investment Partners LLC bought a new position in shares of HealthEquity during the second quarter worth $58,000. Finally, Northwestern Mutual Wealth Management Co. boosted its position in shares of HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after acquiring an additional 418 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Saturday. JPMorgan Chase & Co. upped their price target on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. KeyCorp decreased their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Royal Bank Of Canada upped their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. Finally, Jefferies Financial Group upped their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $121.31.

Insider Activity

In related news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Monday, October 20th. The shares were sold at an average price of $92.07, for a total value of $138,105.00. Following the transaction, the executive vice president owned 76,979 shares of the company’s stock, valued at $7,087,456.53. This trade represents a 1.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the transaction, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,281 shares of company stock valued at $859,867 in the last 90 days. Company insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $96.50 on Monday. The firm has a 50-day moving average price of $92.21 and a 200-day moving average price of $94.67. The firm has a market capitalization of $8.31 billion, a PE ratio of 58.49, a price-to-earnings-growth ratio of 1.39 and a beta of 0.47. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $325.80 million during the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.